The Asia-Pacific OTC drugs market is anticipated to grow at a CAGR of 7.9% during the forecast period (2019-2025). The market growth is attributed to the increasing trend of self-medication in the region coupled with the increasing healthcare spending. Major economies covered in the study of the Asia-Pacific OTC drugs industry report covers the analysis of China, Japan, India, and Rest of Asia-Pacific. Among these, India is an emerging region in the OTC drug landscape. Some of the major players in the OTC drug industry in India include Cipla, Dabur, Emami, GlaxoSmithKline, Piramal, and others.
Browse the full report description Asia-Pacific OTC Drugs Market Size, Share & Trends Analysis Report By Product Type (Analgesics & Pain Relievers; Cough, Cold & Flu Products; Vitamin & Mineral Supplements; Ophthalmic Products; and Others), By Distribution Channel (Retail & Supermarkets and Online Platform), and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/asia-pacific-over-the-counter-otc-drugs-market
Moreover, the Indian government is showing a keen interest in the growth of the Indian pharmaceutical sector among the other countries. The initiatives by the government such as Pharma Vision 2020, National Biopharma Mission, and National Health Policy schemes are driving the OTC drugs industry.
Some of the key driving factors for the growth of the Indian OTC drugs industry are as follows:
Market Coverage
o By Product Type
o By Distribution Channel
o China
o India
o Japan
o Rest of Asia-Pacific
Key Questions Addressed by the Report
European OTC Drugs Market Report Segment
By Product Type
By Distribution Channel
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/asia-pacific-over-the-counter-otc-drugs-market